Clinical Trials

Stroke Study - Warfarin vs. Aspirin

Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF)

Protocol ID

02.02.098T

Protocol Description

The purpose of this research study is to determine which of two commonly used treatments Warfarin (Coumadin), an anticoagulant (blood thinner), or aspirin, a drug which reduces platelet function (keeps blood from clotting) is better for preventing death and stroke in patients with poor heart (cardiac) function. Both Warfarin and Aspirin are FDA approved for the use of reducing the risk of death associated with stroke and heart attacks.